140 related articles for article (PubMed ID: 4433493)
1. Management of the dry eye in Sjogren's syndrome.
Williamson J; Doig WM; Forrester JV; Tham MH; Wilson T; Whaley K; Dick WC
Br J Ophthalmol; 1974 Sep; 58(9):798-805. PubMed ID: 4433493
[No Abstract] [Full Text] [Related]
2. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
Marsh P; Pflugfelder SC
Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
[TBL] [Abstract][Full Text] [Related]
3. [Current treatments of xerophthalmia in Sjögren's syndrome].
Baudouin C; Pisella PJ; Brignole F
Rev Med Interne; 2004 May; 25(5):376-82. PubMed ID: 15110955
[TBL] [Abstract][Full Text] [Related]
4. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome.
Hong S; Kim T; Chung SH; Kim EK; Seo KY
J Ocul Pharmacol Ther; 2007 Feb; 23(1):78-82. PubMed ID: 17341155
[TBL] [Abstract][Full Text] [Related]
5. Sjogren's syndrome. I. Sicca components.
Whaley K; Williamson J; Chisholm DM; Webb J; Mason DK; Buchanan WW
Q J Med; 1973 Apr; 42(166):279-304. PubMed ID: 4785436
[No Abstract] [Full Text] [Related]
6. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
[TBL] [Abstract][Full Text] [Related]
7. [Precorneal film and its significance in the therapy of "dry eye"].
Jaeger W
Buch Augenarzt; 1981; (84):40-53. PubMed ID: 7284872
[No Abstract] [Full Text] [Related]
8. "Dry eye" following blepharoplasty. Cause or coincidence?
Swartz RM; Schultz RC; Seaton JR
Plast Reconstr Surg; 1974 Dec; 54(6):644-7. PubMed ID: 4438463
[No Abstract] [Full Text] [Related]
9. [Characteristics of keratoconjunctivitis sicca in Sjögren's disease and syndrome].
Safonova TN; Iudina IuV
Ter Arkh; 1988; 60(4):30-1. PubMed ID: 3394092
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and possibilities of treatment of eye lesions in Sjögren's syndrome].
Iudina IuV
Vestn Oftalmol; 1976; (3):74-9. PubMed ID: 969124
[No Abstract] [Full Text] [Related]
11. Lacrimal punctum occlusion in the treatment of severe keratoconjunctivitis Sicca caused by Sjögren syndrome: a uniocular evaluation.
Mansour K; Leonhardt CJ; Kalk WW; Bootsma H; Bruin KJ; Blanksma LJ;
Cornea; 2007 Feb; 26(2):147-50. PubMed ID: 17251802
[TBL] [Abstract][Full Text] [Related]
12. Sjögren's syndrome. A dry-eyed diary.
Tarail J
Am J Nurs; 1987 Mar; 87(3):324-6. PubMed ID: 3644597
[No Abstract] [Full Text] [Related]
13. Swimmer's goggles for keratoconjunctivitis sicca.
Poirier RH; Ryburn FM; Israel CW
Arch Ophthalmol; 1977 Aug; 95(8):1405-6. PubMed ID: 889518
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
Akpek EK; Lindsley KB; Adyanthaya RS; Swamy R; Baer AN; McDonnell PJ
Ophthalmology; 2011 Jul; 118(7):1242-52. PubMed ID: 21459453
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Gougerot-Sjögren's disease. Therapeutic note apropos of 2 cases].
Charleux J
Bull Soc Ophtalmol Fr; 1967 Feb; 67(2):339-41. PubMed ID: 5612445
[No Abstract] [Full Text] [Related]
16. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the management of ocular complications of Sjögren's syndrome.
Samarkos M; Moutsopoulos HM
Curr Allergy Asthma Rep; 2005 Jul; 5(4):327-32. PubMed ID: 15967078
[TBL] [Abstract][Full Text] [Related]
18. Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca.
Friedlaender MH
Rheum Dis Clin North Am; 1992 Aug; 18(3):591-608. PubMed ID: 1496163
[TBL] [Abstract][Full Text] [Related]
19. [Nonsteroidal anti-inflammatory agents: their topical use in the treatment of xerophthalmia secondary to Sjögren's syndrome].
Giorgi D; Giorgi A; D'Angelo G; Verrastro G; Lai S; Grandinetti F; Gabrieli CB
Recenti Prog Med; 1997 Sep; 88(9):397-400. PubMed ID: 9380944
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
Kono I; Matsumoto Y; Kono K; Ishibashi Y; Narushima K; Kabashima T; Yamane K; Sakurai T; Kashiwagi H
J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
